The autophagy claims, examined

What autophagy is

Autophagy is how cells break down and recycle their own damaged components — misfolded proteins, worn-out organelles, aggregates. It is upregulated when nutrients are scarce, because a cell that cannot import raw material starts cannibalising its own spare parts. The 2016 Nobel Prize in Physiology or Medicine went to work on its mechanisms, so nobody is disputing that it matters.

The leap that does not follow: because fasting increases autophagy in model organisms, a specific human fasting duration produces a specific health benefit.

The measurement problem

Autophagy is hard to measure in living humans. It is a flux — a rate of turnover — not a quantity, and quantifying it properly requires tissue samples and often blocking agents. You cannot assess it from a blood test, which is why almost every human "autophagy" claim rests on indirect surrogate markers.

The best human data comes from fasting-mimicking diet trials. One randomised trial compared fasting-mimicking diets with low and high protein content and measured cardiometabolic health alongside autophagy markers ^[2], Mechanistic work on spermidine has identified it as essential for fasting-mediated autophagy and longevity in models ^[8], and separate trials of fasting-mimicking diets report changes in hepatic and blood markers, discussed on the extended-fasting section of the protocols page.

Human fasting-induced autophagy

Where the hour counts came from

Nowhere. There is no human trial that fasted groups for 12, 16, 24 and 48 hours, biopsied tissue, and reported an autophagy threshold. The numbers you see in infographics are extrapolated from rodent studies — and mice have a metabolic rate roughly seven times higher than ours, so their fasting timescales do not transfer.

Where fasting biology is being tested seriously

Oncology, mostly. A systematic review examined fasting-mimicking diets as a way to reprogram tumour metabolism ^[1], and a Cell Metabolism review covers the preclinical and clinical evidence for cyclic fasting-mimicking diets in cancer treatment ^[7]. An older review of fasting's impact on health and disease processes remains a reasonable overview of the mechanistic landscape ^[7].

This is serious research. It is also research into a supervised clinical intervention in seriously ill people, which is a different thing from skipping breakfast.

Other contexts where fasting has been studied

• Critical care. The metabolic effects of intermittent versus continuous feeding have been examined in critically ill patients ^[5].
• Long COVID. A randomised crossover trial tested intermittent fasting and a no-sugar diet for symptoms ^[3].
• Chemotherapy interaction. Sustained alternate-day fasting potentiated doxorubicin cardiotoxicity ^[4] — a reminder that fasting is not inherently protective.

Common questions